Zdrowie i gospodarka · 01/02/2019

FDA Releases Draft Guidance for Rare Diseases Drug Development

The Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies develop more efficient and successful treatments for rare diseases, addressing key aspects of drug development and interactions with the Agency.